“I believed in the power of PhysioPD when I first saw it twenty-five years ago, I’ve had a passion for it ever since, and now we have enough experience that I know it works.”
About Rosa & Co
Rosa was founded in 2002 and remains an employee-owned, science-focused, and client-friendly firm. Today, Rosa is the worldwide commercial leader in PhysioPD-style Research, with comprehensive basic biology and therapeutic experience, industry-leading modeling expertise, and repeat research engagements with a majority of the Top 20 pharmaceutical companies.
Rosa's ForecastMD Platforms, which offers a credible methodology for determining expected physician uptake for healthcare products, was started by Bill Brastow, Ph.D., in 2005. Our models have helped shape first-in-class markets including novel therapy combinations for HIV and molecular diagnostic tests for Oncology.
Rosa’s staff bring more than a century of aggregate experience in applying modeling to the inherent challenges faced by drug developers and have authored hundreds of scientific posters, conference presentations, relevant patents, and peer-reviewed publications.
Rosa Leadership in the Community
Host Worldwide Webinar Series: Impact of Modeling & Simulation in Drug DevelopmentPresentations from the pharmaceutical industry, academia, and regulatory agencies
International Society of PharmacometricsChair of the QSP Special Interest Group
Member of the Variability, Uncertainty, and Error in QSP Models Working Group
Co-Chair of the Integrating QSP and Machine Learning Working Group
Member of the Immuno-Oncology Working Group
Former Member of the QSP Workflows and Methodologies Working Group
Former Chair of the QSP in Regulatory Interactions Working Group
Former Secretary of the QSP SIG
Strategic Cooperation Agreement with MathWorks®, provider of MATLAB®, and SimBiology®
The International Society of Pharmacometrics has announced the Outstanding Research Manuscript Award for 2023 is “Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clini... Read More
Rosa will present a talk and a poster at the Fourteenth American Conference on Pharmacometrics (ACoP14). Dr. Friedrich will present “QSP Modelers – Take Your Data Seriously, Not Literally!” during the Roller Coaster 2 session on Wednesday, 11/8/23. D... Read More
ACoP14 2023November 5 - 8, 2023Fourteenth American Conference on Pharmacometrics (ACoP14). https://www.go-acop.org/National Harbor, MD
Proventa International’s 10th Annual Clinical Operations Strategy MeetingNovember 9, 2023Rosa's Brian Schneider and Matt Marano will run a Roundtable. More information is available at https://proventainternational.com/events/clinical/usa-east/boston/clinical-operations-meeting-east-coast-november-2023/Le Meridien Cambridge, Massachusetts, USA
Health Economics & Outcomes Research SummitDecember 12 - 14, 2023The Health Economics & Outcomes Research Summit is a focused gathering to advance tactical and strategic conversations, leveraging innovative methods to demonstrate the value proposition of new drugs to secure formulary and market access. https://heor-summit.com/Philadelphia, PA
PAGE 2023June 27- 30, 2023Rosa presented two posters at the Population Approach Group Europe (PAGE) 2023 Meeting.A Coruña, Spain
Creating a Roadmap to Quantitative Systems Pharmacology-informed Rare Disease Drug DevelopmentMay 11, 2023The U.S. Food and Drug Administration (FDA)- in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI)- will host a one-day virtual public workshop entitled “Creating a Roadmap to Quantitative Systems Pharmacology-informed Rare Disease Drug Development” For registration information, see https://cersi.umd.edu/event/17946/creating-a-roadmap-to-quantitative-systems-pharmacology-informed-rare--disease-drug-development.Virtual